Repurposing niclosamide as a novel anti-SARS-Cov-2 drug by restricting entry protein CD147

Mostrar otras versiones (1)

BACKGROUND: The burst of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing the global COVID-19 pandemic. But until today only limited numbers of drugs are discovered to treat COVID-19 patients. Even worse, the rapid mutations of SARS-CoV-2 compromise the effectiveness of existi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zhe, Zhang, Qi, Wu, Xiaoqing, Hao, Siyuan, Hao, Xinbao, Jones, Elizabeth, Zhang, Yuxia, Qiu, Jianming, Xu, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120763/
https://www.ncbi.nlm.nih.gov/pubmed/37090542
http://dx.doi.org/10.21203/rs.3.rs-2763207/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120763/
https://www.ncbi.nlm.nih.gov/pubmed/37090542
http://dx.doi.org/10.21203/rs.3.rs-2763207/v1

Ejemplares similares